UNSPSC 51391607: Propylhexedrine

This classification denotes an alpha-adrenergic agonist with the molecular formula C10H21N, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier LQU92IU8LL, chemically known as propylhexedrine, dl- but generally known as propylhexedrine, which bears US NIH Compound Identifier 7558. European Medicines Agency schedules Propylhexedrine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10121MIG. The term PROPYLHEXEDRINE is an International Non-Proprietary Name.

UNSPSC 51391607 Propylhexedrine, a Commodity code, shows minimal recent state and local procurement activity. The single recent opportunity in the dataset — Seminole County, Florida's IFB60459723LAS for Naloxone and Drug Deactivation Systems — does not align with the propylhexedrine commodity scope. Naloxone is an opioid antagonist used in overdose reversal and safe drug deactivation systems, distinct from propylhexedrine, a nasal decongestant. The mismatch suggests either a cataloging anomaly in the source data or that state and local governments are not actively soliciting propylhexedrine under this code at present.

No additional recent solicitations support propylhexedrine procurement activity across state or local jurisdictions. Without a meaningful body of recent opportunities, the code presents limited visibility into current buying patterns, issuing-body concentration, or geographic demand signals. Firms evaluating this code should verify whether state and local procurement offices are using it for actual propylhexedrine purchases or whether the commodity is being procured under alternative taxonomies or supplier agreements.